ALCON INC (2U3.DE) Stock Fundamental Analysis
FRA:2U3 - CH0432492467 - Common Stock
67 EUR
-1.02 (-1.5%)
We assign a fundamental rating of 6 out of 10 to 2U3. 2U3 was compared to 58 industry peers in the Health Care Equipment & Supplies industry. While 2U3 has a great health rating, its profitability is only average at the moment. 2U3 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 2U3 was profitable.
2U3 had a positive operating cash flow in the past year.
2U3 had positive earnings in 4 of the past 5 years.
2U3 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.61%, 2U3 is in line with its industry, outperforming 55.17% of the companies in the same industry.
2U3 has a Return On Equity of 5.09%. This is comparable to the rest of the industry: 2U3 outperforms 48.28% of its industry peers.
With a Return On Invested Capital value of 3.93%, 2U3 is not doing good in the industry: 60.34% of the companies in the same industry are doing better.
2U3 had an Average Return On Invested Capital over the past 3 years of 3.01%. This is significantly below the industry average of 8.86%.
The 3 year average ROIC (3.01%) for 2U3 is below the current ROIC(3.93%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.61% | ||
| ROE | 5.09% | ||
| ROIC | 3.93% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
1.3 Margins
2U3 has a better Profit Margin (11.28%) than 72.41% of its industry peers.
In the last couple of years the Profit Margin of 2U3 has grown nicely.
The Operating Margin of 2U3 (14.07%) is better than 68.97% of its industry peers.
In the last couple of years the Operating Margin of 2U3 has grown nicely.
With a Gross Margin value of 54.25%, 2U3 perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
In the last couple of years the Gross Margin of 2U3 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.07% | ||
| PM (TTM) | 11.28% | ||
| GM | 54.25% |
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2. Health
2.1 Basic Checks
2U3 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, 2U3 has more shares outstanding
Compared to 5 years ago, 2U3 has more shares outstanding
2U3 has a better debt/assets ratio than last year.
2.2 Solvency
2U3 has an Altman-Z score of 4.23. This indicates that 2U3 is financially healthy and has little risk of bankruptcy at the moment.
2U3 has a Altman-Z score of 4.23. This is amongst the best in the industry. 2U3 outperforms 82.76% of its industry peers.
2U3 has a debt to FCF ratio of 3.58. This is a good value and a sign of high solvency as 2U3 would need 3.58 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.58, 2U3 is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
2U3 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, 2U3 is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.58 | ||
| Altman-Z | 4.23 |
ROIC/WACC0.83
WACC4.73%
2.3 Liquidity
A Current Ratio of 2.70 indicates that 2U3 has no problem at all paying its short term obligations.
The Current ratio of 2U3 (2.70) is better than 75.86% of its industry peers.
2U3 has a Quick Ratio of 1.66. This is a normal value and indicates that 2U3 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.66, 2U3 is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.7 | ||
| Quick Ratio | 1.66 |
3. Growth
3.1 Past
2U3 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.23%.
The Earnings Per Share has been growing by 10.04% on average over the past years. This is quite good.
Looking at the last year, 2U3 shows a small growth in Revenue. The Revenue has grown by 4.82% in the last year.
2U3 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.71% yearly.
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
3.2 Future
Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.44% on average per year.
2U3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y1.91%
EPS Next 2Y8.54%
EPS Next 3Y10.89%
EPS Next 5Y12.44%
Revenue Next Year5.61%
Revenue Next 2Y6.56%
Revenue Next 3Y6.62%
Revenue Next 5Y6.3%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 25.97, 2U3 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 2U3 is valued a bit cheaper than the industry average as 72.41% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.02. 2U3 is around the same levels.
The Price/Forward Earnings ratio is 21.87, which indicates a rather expensive current valuation of 2U3.
Based on the Price/Forward Earnings ratio, 2U3 is valued a bit cheaper than the industry average as 65.52% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, 2U3 is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.97 | ||
| Fwd PE | 21.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 2U3 is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, 2U3 is valued a bit cheaper than 72.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.02 | ||
| EV/EBITDA | 16.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 2U3 does not grow enough to justify the current Price/Earnings ratio.
2U3 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)13.57
PEG (5Y)2.59
EPS Next 2Y8.54%
EPS Next 3Y10.89%
5. Dividend
5.1 Amount
2U3 has a yearly dividend return of 0.44%, which is pretty low.
Compared to an average industry Dividend Yield of 2.16, 2U3 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, 2U3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.44% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
2U3 pays out 11.61% of its income as dividend. This is a sustainable payout ratio.
DP11.61%
EPS Next 2Y8.54%
EPS Next 3Y10.89%
FRA:2U3 (9/8/2025, 7:00:00 PM)
67
-1.02 (-1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners68.39%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap33.48B
Analysts80
Price Target92.38 (37.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.44% |
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP11.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.84%
Min EPS beat(2)-4.26%
Max EPS beat(2)0.57%
EPS beat(4)3
Avg EPS beat(4)1.13%
Min EPS beat(4)-4.26%
Max EPS beat(4)7.68%
EPS beat(8)6
Avg EPS beat(8)1.96%
EPS beat(12)8
Avg EPS beat(12)2.89%
EPS beat(16)12
Avg EPS beat(16)5.61%
Revenue beat(2)0
Avg Revenue beat(2)-1.99%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)-0.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)1
Avg Revenue beat(8)-1.32%
Revenue beat(12)2
Avg Revenue beat(12)-0.76%
Revenue beat(16)6
Avg Revenue beat(16)0.43%
PT rev (1m)-4.98%
PT rev (3m)N/A
EPS NQ rev (1m)-0.63%
EPS NQ rev (3m)-4.4%
EPS NY rev (1m)-5.66%
EPS NY rev (3m)-5.66%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)0.57%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.97 | ||
| Fwd PE | 21.87 | ||
| P/S | 3.96 | ||
| P/FCF | 27.02 | ||
| P/OCF | 18.52 | ||
| P/B | 1.78 | ||
| P/tB | 11.4 | ||
| EV/EBITDA | 16.32 |
EPS(TTM)2.58
EY3.85%
EPS(NY)3.06
Fwd EY4.57%
FCF(TTM)2.48
FCFY3.7%
OCF(TTM)3.62
OCFY5.4%
SpS16.94
BVpS37.54
TBVpS5.88
PEG (NY)13.57
PEG (5Y)2.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.61% | ||
| ROE | 5.09% | ||
| ROCE | 4.85% | ||
| ROIC | 3.93% | ||
| ROICexc | 4.14% | ||
| ROICexgc | 12.86% | ||
| OM | 14.07% | ||
| PM (TTM) | 11.28% | ||
| GM | 54.25% | ||
| FCFM | 14.64% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexcg growth 3Y2.95%
ROICexcg growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score6
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.58 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 53.75% | ||
| Cap/Sales | 6.72% | ||
| Interest Coverage | 7.59 | ||
| Cash Conversion | 80.39% | ||
| Profit Quality | 129.73% | ||
| Current Ratio | 2.7 | ||
| Quick Ratio | 1.66 | ||
| Altman-Z | 4.23 |
F-Score6
WACC4.73%
ROIC/WACC0.83
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
EPS Next Y1.91%
EPS Next 2Y8.54%
EPS Next 3Y10.89%
EPS Next 5Y12.44%
Revenue 1Y (TTM)4.82%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
Revenue Next Year5.61%
Revenue Next 2Y6.56%
Revenue Next 3Y6.62%
Revenue Next 5Y6.3%
EBIT growth 1Y12.13%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year44.89%
EBIT Next 3Y21.32%
EBIT Next 5Y15.54%
FCF growth 1Y202.71%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y71.52%
OCF growth 3Y15.59%
OCF growth 5Y17.69%